Skip to main content
Clinical Trials/NCT04693702
NCT04693702
Completed
Not Applicable

Observational Study of Vision Improvement in Patients With Retinal Disorders

Optimal Acuity Corporation1 site in 1 country54 target enrollmentOctober 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Age-related Macular Degeneration
Sponsor
Optimal Acuity Corporation
Enrollment
54
Locations
1
Primary Endpoint
CDVA
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to assess the vision improvement achieved by patients with retinal disorders who received corneal treatments by a low vision aid device.

Detailed Description

The purpose of this study is to assess the vision improvement achieved by patients with retinal disorders, including age-related macular degeneration and diabetic macular edema, who received corneal treatments by a low vision aid device. Patient records will be analyzed to determine measures of vision improvement including best spectacle-corrected distance visual acuity (CDVA). Analyses will include descriptive statistics and correlation between outcomes and baseline characteristics.

Registry
clinicaltrials.gov
Start Date
October 1, 2021
End Date
March 16, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Female or male
  • Patient is at least 50 years old
  • Patient has diagnosed retinal disorder that causes central vision loss in one or both eyes
  • Treated eyes, at time of treatment, were pseudophakic or phakic with no significant vision loss due to cataract
  • Patient had moderate to severe baseline vision impairment with CDVA of 20/63 or worse (decimal = 0.317 or less; logMAR greater than or equal to 0.50) in the treated eye(s)
  • Patient CDVA records are available at baseline and at 1m or longer post-Tx times

Exclusion Criteria

  • 1 - Corneal disease or disorder in either eye 2 - Increased intraocular pressure (above 20mm Hg), glaucoma or history of glaucoma 3 - Presence or history of any other condition or finding that, in the opinion of the investigator, makes the patient unsuitable for retrospective observational study

Outcomes

Primary Outcomes

CDVA

Time Frame: 12 months

Best spectacle-corrected distance visual acuity

Study Sites (1)

Loading locations...

Similar Trials